Wedelolactone, a Component from Eclipta prostrata (L.) L., Inhibits the Proliferation and Migration of Head and Neck Squamous Cancer Cells through the AhR Pathway.
Current pharmaceutical biotechnology(2022)
摘要
Our study identifies wedelolactone as a major active component of Ecliptae prostrata (L.) L. with promising anti-cancer properties against head and neck squamous cancer cells.
更多查看译文
关键词
AhR,CYP1A1,CYP1B1,Ecliptae prostrata (L.) L,Wedelolactone,head and neck squamous cancer cells
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要